One of the critical pathways implicated in bladder cancer progression and resistance mechanisms is the phosphoinositide 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling pathway8,9. This evidence concerns the gene MTOR and urinary bladder carcinoma.